NCT06987760

Brief Summary

Comparing the Efficiency, Effectiveness, and Safety of fURS lithotripsy with Similar RESDs in the Treatment of Upper Urinary Tract Stones.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
206

participants targeted

Target at P75+ for not_applicable

Timeline
8mo left

Started Mar 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress64%
Mar 2025Dec 2026

First Submitted

Initial submission to the registry

February 15, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

March 19, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 23, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

May 23, 2025

Status Verified

February 1, 2025

Enrollment Period

1.5 years

First QC Date

February 15, 2025

Last Update Submit

May 22, 2025

Conditions

Keywords

UrolithiasisRatio of Endoscope-Sheath DiameterFlexible ureteroscope

Outcome Measures

Primary Outcomes (1)

  • Success rate of ureteral access sheath insertion

    Proportion of successful ureteral implantation, success rate = number of successful cases/total number of cases

    From enrollment to completion of surgery

Secondary Outcomes (4)

  • The condition of ureter injury

    24 hours

  • Stone clearance rate

    up to 8 weeks.

  • Operation time

    24 hours

  • The incidence of surgical complications

    7 days

Study Arms (2)

7.5Fr fURS and 10Fr UAS

EXPERIMENTAL

7.5Fr disposable electronic flexible ureteroscope combine with 10Fr distally deflectable ureteral access sheath.

Procedure: flexible ureteroscope urolithiasis

9.0Fr fURS and 12Fr UAS

ACTIVE COMPARATOR

9.0Fr disposable electronic flexible ureteroscope combine with 12Fr distally deflectable ureteral access sheath.

Procedure: flexible ureteroscope urolithiasis

Interventions

Using flexible ureteroscope combine with urethral access sheath to treatment urolithiasis

7.5Fr fURS and 10Fr UAS9.0Fr fURS and 12Fr UAS

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- 1.Patients with kidney stones or upper ureteral stones with a cumulative diameter of less than 3 cm are selected for ureteral soft lens holmium laser lithotripsy.
  • Age 18 to 80 years old, gender unlimited. 3.The subjects have no mental illness or language dysfunction, can understand the situation of the study and can sign informed consent.

You may not qualify if:

  • Patients with a history of ureteral stenosis or who have undergone open or laparoscopic ureteral or renal lithotomy.
  • Patients with fever one week before surgery 3.Pregnant women and menstruating patients. 4.Patients with combined systemic disease or inability to tolerate anesthesia. 5.Patients undergoing simultaneous surgery for bilateral upper urinary tract stones.
  • Patients with ureteral stent indwelling before surgery. 7.In patients with severe hydronephrosis, the separation of the renal collecting system is greater than 4 cm.
  • Patients with renal anatomic malformations such as polycystic kidney, horseshoe kidney, and ectopic kidney.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Ningbo University

Ningbo, Zhejiang, 315010, China

RECRUITING

MeSH Terms

Conditions

Urolithiasis

Condition Hierarchy (Ancestors)

Urologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
9.0Fr disposable electronic flexible ureteroscope combine with 12Fr distally deflectable ureteral access sheath.
Purpose
TREATMENT
Intervention Model
FACTORIAL
Model Details: 7.5Fr disposable electronic flexible ureteroscope combine with 10Fr distally deflectable ureteral access sheath.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 15, 2025

First Posted

May 23, 2025

Study Start

March 19, 2025

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

May 23, 2025

Record last verified: 2025-02

Locations